Skip to main content
. 2019 May 22;86(6):676–686. doi: 10.1016/j.bjorl.2019.04.008

Figure 2.

Figure 2

Kaplan–Meier curves for patients receiving cisplatin ≥200 mg/m2 and <200 mg/m2. (A) Overall survival curve between ≥200 mg/m2 and <200 mg/m2; (B) locally recurrence-free survival curve between ≥200 mg/m2 and <200 mg/m2; (C) regional recurrence-free survival curve between ≥200 mg/m2 and <200 mg/m2, (D) distant metastasis-free survival curve between ≥200 mg/m2 and <200 mg/m2.